Patent · US Active

Methods and compositions for treating cancer and infectious diseases

US11213583B2 · kind B2 · utility

0Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2015
Grant dateJan 4, 2022
Priority date
Expiry dateFeb 5, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/57
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compositions comprising a CD4 lymphocyte depleting agent; and methods of using the compositions to treat, prevent, reduce the severity of and/or slow the progression of a condition in a subject. The invention also relates to use of combinations of a CD4 lymphocyte depleting agent and at least one additional agent to treat, prevent, reduce the severity of and/or slow the progression of a condition in a subject. The additional agent may be an immune check point inhibitor, an adoptive immune therapeutic, an immune adjuvant, or an immune modulating agent, or their combinations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.